Leukemia Clinical Trials in Massachusetts

Showing 701-720 of 1,457 trials

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

NCT05669105

The study objective is to collect biospecimen samples (e.g., whole blood) from participants diagnosed with active lung cancer to investigate the immune response to develop treatments and therapies.

Non Small Cell Lung Cancer

Sanguine Biosciences200 participantsStarted Feb 2022

Waltham, Massachusetts, United States

TERMINATEDPhase 1/226 miles

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

NCT03422679

This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.

Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more

Cellestia Biotech AG79 participantsStarted Dec 2017

Santa Monica, California, United States • Boston, Massachusetts, United States • Houston, Texas, United States +14 more locations

COMPLETEDPhase 1/226 miles

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

NCT02915523

The purpose of this study is to determine the biologically active dose of entinostat, when given in combination with avelumab, that is safe and warrants further investigation. Additionally, this study will evaluate the effectiveness of entinostat in combination with avelumab at the determined dose in terms of progression free survival compared to avelumab plus placebo in participants with refractory or recurrent epithelial ovarian cancer.

Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer

Syndax Pharmaceuticals140 participantsStarted Dec 2016

Tampa, Florida, United States • West Palm Beach, Florida, United States • Chicago, Illinois, United States +9 more locations

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Leukemia Trials in Other Cities

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Food Oral Immunotherapy for Peanut Allergy

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Mite Asthma Pediatric Immunotherapy Trial

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Survival Prolongation by Rationale Innovative Genomics

International Lung Screen Trial (ILST)

International Chronic Myeloid Leukemia Pediatric Study

Other Conditions in Massachusetts